Politicians from across the political spectrum are up in arms over healthcare giant Sanofi’s plans to sell France’s best-known medical drug Doliprane to US investors, a move critics say would lead to a “loss of sovereignty” for the country in a sensitive industry.
Related Posts
Paris neighbourhoods: Exploring Père-Lachaise cemetery and the 20th arrondissement
In this edition of French Connections Plus, Genie Godula and Florence Villeminot continue their tour of Paris with a stop in the eastern 20th arrondissement. […]
Archaeological dig at Notre-Dame unearths 2,000 years of history
The tragic 2019 fire at Notre-Dame Cathedral led to major discoveries during restoration work. Archaeologists unearthed treasures dating back from antiquity to the 19th century.
Seven charged for cyberbullying campaign against Paris Olympics’ artistic director
French authorities say they have charged seven individuals for allegedly harassing Thomas Jolly, the artistic director for the 2024 Summer Olympics. The suspects must appear […]